Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SLC27A5 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5101463
Description
Antibody detects endogenous levels of total SLC27A5.
The protein encoded by this gene is an isozyme of very long-chain acyl-CoA synthetase (VLCS). It is capable of activating very long-chain fatty-acids containing 24- and 26-carbons. It is expressed in liver and associated with endoplasmic reticulum but not with peroxisomes. Its primary role is in fatty acid elongation or complex lipid synthesis rather than in degradation. This gene has a mouse ortholog.
Specifications
SLC27A5 | |
Polyclonal | |
Unconjugated | |
SLC27A5 | |
ACSB; ACSVL6; BA-CoA ligase; BACS; BAL; bile acid CoA ligase; bile acid-CoA ligase; Bile acyl-CoA synthetase; cholate--CoA ligase; FACVL3; FATP5; FATP-5; Fatty acid transport protein 5; fatty-acid-Coenzyme A ligase, very long-chain 3; FLJ22987; rBAL-1; Slc27a5; solute carrier family 27 (fatty acid transporter), member 5; solute carrier family 27 member 5; ve; Very long-chain acyl-CoA synthetase homolog 2; very long-chain acyl-CoA synthetase-related protein; very long-chain acyl-Coenzyme A dehydrogenase synthase related; Vlacsr; VLACS-related; VLCSH2; VLCS-H2 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
10998, 26459, 79111 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q4LDG0, Q9ES38, Q9Y2P5 | |
SLC27A5 | |
A synthesized peptide derived from human SLC27A5(Accession Q9Y2P5), corresponding to amino acid residues P486-V536. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction